IHS FormWeb
Approved Formulary
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
IHS FormWeb
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Search results for:
meropenem
meropenem
Brand names:
Merrem
Form
Strength
POWDER FOR INJECTION, INTRAVENOUS
500 mg; 1000 mg
Display
Carbapenems
Class:
08120708
Medication comments:
β-Lactam Use/Allergies Policy
Extended Interval Policy
Pediatric IV prep/admin
Per policy, these drugs are subject to renal dosing adjustments by pharmacy.
Renal Dosing Program
View all
Generic + Route
(Brand)
• Indications
Usual Adult Dose
Comments
Renal Dosage Adjustments
meropenem
IV
(
Merrem
©
)
• CNS infections
• Necrotizing fasciitis
• Bone/Joint Infection
2 gm q8h
(3 hr infusion)
Refer to
Policy
CrCl > 50 mL/min: No adjustment necessary
CrCl 25-49 mL/min: 2 gm q12h
CrCl 10-24 mL/min: 1 gm q12h
CrCl < 10 mL/min, HD: 1 gm q24h (give dose after HD)
Continuous renal replacement therapy
(CRRT): 2 gm q12h
meropenem
IV
(
Merrem
©
)
•
Pseudomonas
infection
(susceptible to meropenem)
•
Acinetobacter
infection
(susceptible to meropenem)
1 gm q8h
(3 hr infusion)
Refer to
Policy
CrCl > 50 mL/min: No adjustment necessary
CrCl 25-49 mL/min: 1 gm q12h
CrCl 10-24 mL/min: 500 mg q12h
CrCl < 10 mL/min, HD: 500 mg q24h (give dose after HD)
Continuous renal replacement therapy
(CRRT): 1 gm q12h
meropenem
IV
(
Merrem
©
)
• Pneumonia
• Intra-abdominal infection
• Neutropenic fever
• Infections caused by ESBLs or cefTRIAXone-resistant organisms
500 mg q6h
(30 min infusion)
Refer to
Policy
CrCl > 50 mL/min: No adjustment necessary
CrCl 25-49 mL/min: 500 mg q8h
CrCl 10-24 mL/min: 500 mg q12h
CrCl < 10 mL/min, HD: 500 mg q24h (give dose after HD)
Continuous renal replacement therapy
(CRRT): 500 mg q6h
Per policy, these antibiotic medications may be given IV push.
View all
Guidelines
generic (Brand)
Reconstitution Amount
Reconstitution Diluent
Give over
Copy/Paste comments for PharmNet
meropenem (Merrem)
500 mg vial = 10 ml
Sterile Water for Injection
3-5 mins
Dilute with 10 ml Sterile Water for Injection and give over 3-5 mins.
No IV Push for ≥ 1 gm doses, give via IVPB over 3 hours.
Last updated:
Jul. 26, 2021
Renal Adjustment Policy
meropenem subject to adjustments by pharmacy.
UpToDate
FDA DailyMed Package Insert
MedLinePlus (Patient Information)
MSDS Online
(Brand)
• Indications
Comments
(Merrem©)
• CNS infections
• Necrotizing fasciitis
• Bone/Joint Infection
(3 hr infusion)
Refer to
CrCl 25-49 mL/min: 2 gm q12h
CrCl 10-24 mL/min: 1 gm q12h
CrCl < 10 mL/min, HD: 1 gm q24h (give dose after HD)
Continuous renal replacement therapy
(CRRT): 2 gm q12h
(Merrem©)
• Pseudomonas infection
(susceptible to meropenem)
• Acinetobacter infection
(susceptible to meropenem)
(3 hr infusion)
Refer to
CrCl 25-49 mL/min: 1 gm q12h
CrCl 10-24 mL/min: 500 mg q12h
CrCl < 10 mL/min, HD: 500 mg q24h (give dose after HD)
Continuous renal replacement therapy
(CRRT): 1 gm q12h
(Merrem©)
• Pneumonia
• Intra-abdominal infection
• Neutropenic fever
• Infections caused by ESBLs or cefTRIAXone-resistant organisms
(30 min infusion)
Refer to
CrCl 25-49 mL/min: 500 mg q8h
CrCl 10-24 mL/min: 500 mg q12h
CrCl < 10 mL/min, HD: 500 mg q24h (give dose after HD)
Continuous renal replacement therapy
(CRRT): 500 mg q6h